Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy UBS Group AG

Start price
€51.52
06.03.26 / 50%
Target price
-
06.03.27
Performance (%)
-2.89%
Price
€50.03
21:27
Summary
This prediction is currently active. With a performance of -2.89%, the BUY prediction for Bristol-Myers Squibb by UBS_Group_AG is down slightly. This prediction currently runs until 06.03.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Bristol-Myers Squibb -1.645% -1.645%
iShares Core DAX® 3.075% 0.488%
iShares Nasdaq 100 2.876% 0.081%
iShares Nikkei 225® 5.981% 3.033%
iShares S&P 500 2.231% 0.046%

Comments by UBS_Group_AG for this prediction

In the thread Bristol-Myers Squibb diskutieren

Bristol Myers Squibb (BMY) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for BMY provided by MarketBeat

Stopped prediction by UBS_Group_AG for Bristol-Myers Squibb

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€47.50
07.01.26
€55.55
07.01.27
5.52%
21:27